Personalized Medicine – News and Features
News
Affibody and NIH to Develop Molecular In Vivo Imaging Agents
Affibody will design and develop engineered Affibody® molecules specific for a receptor protein, HER2.
News
DNAPrint Genomics Acquires Kenna Technologies
Key processes will enable development of personalized medicine or 'theranostics' using test/drug combinations.
News
Invader Pharmacogenetic Assay Helps Determine Proper Dosage of Camptosar®
Third Wave and Genzyme Genetics announce preferred marketing relationship for colorectal cancer personalized medicine test
News
Predictive Medicine, Pharmacogenomic Testing, and Prenatal Genetic Screening Support Growth of the Genetic Diagnostics Market
New analysis from Frost & Sullivan, reveals that the predictive medicine, pharmacogenomic, and prenatal and newborn screening will experience significant growth over the next decades.
News
Kyushu University and Perlegen Identify Haplotypes in the Japanese Population
The collaborators have identified common haplotypes that can be used to conduct genetic research on human disease.
News
Lipomics President a Guest Speaker at FDA’s Genomics and Proteomics Interest Group Meeting
Watkins’ presentation addressed metabolomics, focusing on small molecule metabolites.
News
Parc Team Purchases Illumina Genotyping Solutions
Illumina to provide Children's Hospital Oakland Research Institute with reagents and instrumentation.
News
CTT Enters Into R&D Agreement With GE Healthcare
GE Healthcare and CTT will consider exploring a broader use of the CTT technology in medical imaging.
News
Oxford Genome Sciences Licences OGAP Database to UCB
UCB has capitalised on the potential of OGAP database to enhance their drug discovery efforts.
News
DNAPrint Genomics Forms Pharmaceutical Subsidiary
This pharmaceutical subsidiary will focus on personalized medicine.
Advertisement
